Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
April 12, 2016
Patent Application Number
13796586
Date Filed
March 12, 2013
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tolerance induction.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
